For the year ending 2025-12-31, CBIO made $10,844K in revenue. -$153,942K in net income. Net profit margin of -1419.61%.
| Income Statement | 2025-12-31 |
|---|---|
| License revenue | 10,844 |
| Research and development | 138,086 |
| General and administrative | 25,390 |
| Total operating expenses | 163,476 |
| Loss from operations | -152,632 |
| Interest income | 2,875 |
| Interest expense | 2,185 |
| Loss before provision for income taxes | -151,942 |
| Provision for income taxes | 2,000 |
| Net Income Loss | -153,942 |
| Net loss and comprehensive loss | -153,942 |
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)